Sanara MedTech (SMTI) Income from Non-Controlling Interests (2019 - 2026)
Sanara MedTech (SMTI) reported Income from Non-Controlling Interests of -$354.0 for Q1 2026, down 71.84% on a YoY basis from -$1257.3 in Q1 2025, and down 45.08% quarter-over-quarter from -$244.0 in Q4 2025.
Sanara MedTech (SMTI) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends
Sanara MedTech has reported Income from Non-Controlling Interests for 8 years, with the latest figure at -$354.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests fell 71.84% year-over-year to -$354.0; the trailing twelve-month figure through Mar 2026 stood at -$5589.0 (up 97.37% YoY), and the FY2025 full-year result was -$5441.0, up 97.77% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at -$354.0, down from -$244.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $242000.0 in Q4 2022, with the low at -$162020.0 in Q4 2024.
- Historically, Income from Non-Controlling Interests has averaged -$14490.4 across 5 years, with a median of -$25250.0 in 2023.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests jumped 3023.76% — and 2024, when it slumped 541.66%.
- Sanara MedTech's Income from Non-Controlling Interests stood at $242000.0 in 2022, then plunged by 110.43% to -$25250.0 in 2023, then tumbled by 541.66% to -$162020.0 in 2024, then jumped by 99.85% to -$244.0 in 2025, then tumbled by 45.08% to -$354.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$354.0 (Q1 2026), -$244.0 (Q4 2025), and -$955.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 105.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Sanara MedTech | 196.68 Mn | 183.08 Mn | 25.87 Mn | -354.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -354.00 |
| Dec 31, 2025 | -244.00 |
| Sep 30, 2025 | -955.00 |
| Jun 30, 2025 | -4,036.00 |
| Mar 31, 2025 | -206.00 |
| Dec 31, 2024 | -162,020.00 |
| Sep 30, 2024 | -25,284.00 |
| Jun 30, 2024 | -25,188.00 |
| Mar 31, 2024 | -34,859.00 |
| Dec 31, 2023 | -25,250.00 |
| Sep 30, 2023 | -34,579.00 |
| Jun 30, 2023 | -38,447.00 |
| Mar 31, 2023 | -38,429.00 |
| Dec 31, 2022 | 242,000.00 |
| Sep 30, 2022 | -58,792.00 |
| Jun 30, 2022 | -12,512.00 |
| Mar 31, 2022 | -27,181.00 |
| Dec 31, 2021 | -8,277.00 |
| Sep 30, 2021 | -27,491.00 |
| Jun 30, 2021 | -34,481.00 |